Neenu Najeeb, Vitthalrao M Chintalwar, Ketaki Utpat, Unnati Desai
Citation Information :
Najeeb N, Chintalwar VM, Utpat K, Desai U. Utility of D-dimer in Coronavirus Disease 2019. Indian J Respir Care 2024; 13 (3):216-216.
Querol-Ribelles JM, Tenias JM, Grau E, et al. Plasma d-dimer levels correlate with outcomes in patients with community-acquired pneumonia. Chest 2004;126(4):1087–1092. DOI: 10.1378/chest.126.4.1087
Fruchter O, Yigla M, Kramer MR. D-dimer as a prognostic biomarker for mortality in chronic obstructive pulmonary disease exacerbation. Am J Med Sci 2015;349(1):29–35. DOI: 10.1097/MAJ.0000000000000332
Snijders D, Schoorl M, Schoorl M, et al. D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial. Eur J Intern Med 2012;23(5):436–441. DOI: 10.1016/j.ejim.2011.10.019
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054–1062. DOI: 10.1016/S0140-6736(20)30566-3
